Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion type Assertion NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_head.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion description "[Interestingly, C3 treatment resulted in decreased AR binding to target genes accompanied by decreased recruitment of an AR and ?-catenin cofactor, coactivator-associated arginine methyltransferase 1 (CARM1), providing insight into the unrecognized function of ?-catenin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion evidence source_evidence_literature NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion SIO_000772 24019458 NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion wasDerivedFrom befree-2016 NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.
- NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_assertion wasGeneratedBy ECO_0000203 NP1108940.RAYY6c78QC73kJ2m5t9Utz4A29YZAul2grHp3EhIUoj88130_provenance.